Wikidata

(Q43452074)

English

Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience

scientific article published on 10 March 2011

In more languages
default for all languages
No label defined

No description defined

Statements

title
Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21683302
retrieved
23 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43452074&oldid=1989083390"